Proterra Inc. PTRAQ
—
- Market cap
- —
- P/E
- 0.0×
Follow PTRAQ
Growth Flags
show if company had growth for consecutive years
| Sep '23 | Jun '23 | Mar '23 | Dec '22 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.03 | 0.10 | 0.10 | 0.10 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(0.16) | (0.45) | (0.45) | (0.45) | |
P/B ratio |
0.04 | 0.13 | 0.13 | 0.13 | |
Price to Tangible BV |
0.04 | 0.13 | 0.13 | 0.13 | |
EV/Sales |
0.46 | 0.29 | 0.29 | 0.29 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.63) | (0.40) | (0.40) | (0.40) | |
EV/FCF |
(0.55) | (0.34) | (0.34) | (0.34) | |
Quick Ratio |
1.09 | 0.68 | 0.86 | 1.76 | |
Current Ratio |
2.48 | 1.39 | 1.39 | 2.65 | |
Net Debt/EBITDA |
(0.41) | 0.96 | 2.60 | 2.90 | |
Debt/Assets |
25.16% | 21.97% | 21.40% | 14.60% | |
Debt/Equity |
0.65 | 0.68 | 0.66 | 0.24 | |
Asset Turnover |
0.42 | 0.39 | 0.37 | 0.34 | |
Operating CF/Net income |
(13.48) | 2.45 | (0.03) | 1.22 | |
Capex/Depreciation |
(1.83) | (0.12) | (0.81) | (2.02) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
12.76% | 17.41% | 23.29% | 23.47% | |
Selling, General and Administrative Expense of Revenue |
43.44% | 41.49% | 45.12% | 43.21% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
5.20% | 5.14% | 5.42% | 6.91% | |
Graham Net Nets |
9.02 | 2.59 | 2.59 | 2.59 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(3,120.00%) | (1,246.67%) | (1,246.67%) | (1,246.67%) | |
Free Cash Flow Yield |
(2,390.91%) | (851.00%) | (851.00%) | (851.00%) | |
Revenue per Share |
0.38 | 0.38 | 0.35 | 0.36 | |
Operating CF per Share |
(0.31) | (0.33) | 0.03 | (0.44) | |
Capex per Share |
(0.03) | 0.00 | (0.04) | (0.08) | |
Free Cash Flow per Share |
(0.34) | (0.34) | (0.01) | (0.52) | |
Cash per Share |
0.69 | 1.03 | 1.36 | 1.38 | |
Shareholders Equity per Share |
1.21 | 1.17 | 1.20 | 2.30 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.21 | 1.17 | 1.20 | 2.30 | |
Free Cash Flow |
(77.43) | (76.97) | (1.34) | (116.66) | |
Working Capital |
321.49 | 180.29 | 182.14 | 414.76 | |
Capital Expenditures |
(7.11) | (0.92) | (8.45) | (17.64) | |
Net Current Asset Value |
102.75 | 88.38 | 94.37 | 342.12 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.08 | 0.01 | 0.11 | 0.22 | |
Net Profit Margin |
6.05% | (36.16%) | (306.78%) | (101.24%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
91.61 | 82.29 | 88.54 | 105.99 | |
Average Payables |
38.66 | 97.57 | 73.87 | 55.61 | |
Average Inventory |
214.22 | 220.65 | 166.94 | 142.06 | |
Average Assets |
798.16 | 869.44 | 883.83 | 911.17 | |
Average Common Equity |
431.85 | 455.97 | 472.81 | 618.51 |
Columns are period end dates